Papers associated with nerve (and grin1)

Limit to papers also referencing gene:
Show all nerve papers

???pagination.result.count???

???pagination.result.page??? 1

Sort Newest To Oldest

Sort Oldest To Newest

	Postsynaptic and Presynaptic NMDARs Have Distinct Roles in Visual Circuit Development., Kesner P., Cell Rep. July 28, 2020; 32 (4): 107955.
	Neuroprotection by tosyl-polyamine derivatives through the inhibition of ionotropic glutamate receptors., Masuko T., J Pharmacol Exp Ther. November 1, 2009; 331 (2): 522-30.
	The serine protease plasmin cleaves the amino-terminal domain of the NR2A subunit to relieve zinc inhibition of the N-methyl-D-aspartate receptors., Yuan H., J Biol Chem. May 8, 2009; 284 (19): 12862-73.
	Effects of NR1 splicing on NR1/NR3B-type excitatory glycine receptors., Cavara NA., BMC Neurosci. April 6, 2009; 10 32.
	Pharmacological characterization of recombinant NR1/NR2A NMDA receptors with truncated and deleted carboxy termini expressed in Xenopus laevis oocytes., Puddifoot CA., Br J Pharmacol. February 1, 2009; 156 (3): 509-18.
	Binding of spermine and ifenprodil to a purified, soluble regulatory domain of the N-methyl-D-aspartate receptor., Han X., J Neurochem. December 1, 2008; 107 (6): 1566-77.
	Activity-dependent neurotransmitter-receptor matching at the neuromuscular junction., Borodinsky LN., Proc Natl Acad Sci U S A. January 2, 2007; 104 (1): 335-40.
	Equilibrium constants for (R)-[(S)-1-(4-bromo-phenyl)-ethylamino]-(2,3-dioxo-1,2,3,4-tetrahydroquinoxalin-5-yl)-methyl]-phosphonic acid (NVP-AAM077) acting at recombinant NR1/NR2A and NR1/NR2B N-methyl-D-aspartate receptors: Implications for studies of synaptic transmission., Frizelle PA., Mol Pharmacol. September 1, 2006; 70 (3): 1022-32.
	RNA interference of Xenopus NMDAR NR1 in vitro and in vivo., Miskevich F., J Neurosci Methods. April 15, 2006; 152 (1-2): 65-73.
	Tweaking agonist efficacy at N-methyl-D-aspartate receptors by site-directed mutagenesis., Hansen KB., Mol Pharmacol. December 1, 2005; 68 (6): 1510-23.
	Synthesis, binding affinity at glutamic acid receptors, neuroprotective effects, and molecular modeling investigation of novel dihydroisoxazole amino acids., Conti P., J Med Chem. October 6, 2005; 48 (20): 6315-25.
	Pharmacological implications of two distinct mechanisms of interaction of memantine with N-methyl-D-aspartate-gated channels., Chen HS., J Pharmacol Exp Ther. September 1, 2005; 314 (3): 961-71.
	The NR3B subunit does not alter the anesthetic sensitivities of recombinant N-methyl-D-aspartate receptors., Yamakura T., Anesth Analg. June 1, 2005; 100 (6): 1687-1692.
	Glutamate transporter type 3 attenuates the activation of N-methyl-D-aspartate receptors co-expressed in Xenopus oocytes., Zuo Z., J Exp Biol. June 1, 2005; 208 (Pt 11): 2063-70.
	Structural features of the glutamate binding site in recombinant NR1/NR2A N-methyl-D-aspartate receptors determined by site-directed mutagenesis and molecular modeling., Chen PE., Mol Pharmacol. May 1, 2005; 67 (5): 1470-84.
	Molecular interactions of the type 1 human immunodeficiency virus transregulatory protein Tat with N-methyl-d-aspartate receptor subunits., Chandra T., Neuroscience. January 1, 2005; 134 (1): 145-53.
	Monoamines directly inhibit N-methyl-D-aspartate receptors expressed in Xenopus oocytes in a voltage-dependent manner., Masuko T., Neurosci Lett. November 16, 2004; 371 (1): 30-3.
	Differential modulation of NR1-NR2A and NR1-NR2B subtypes of NMDA receptor by PDZ domain-containing proteins., Iwamoto T., J Neurochem. April 1, 2004; 89 (1): 100-8.
	Functional analysis of Caenorhabditis elegans glutamate receptor subunits by domain transplantation., Strutz-Seebohm N., J Biol Chem. November 7, 2003; 278 (45): 44691-701.
	Dynorphin A inhibits NMDA receptors through a pH-dependent mechanism., Kanemitsu Y., Mol Cell Neurosci. November 1, 2003; 24 (3): 525-37.
	Structural model of the N-methyl-D-aspartate receptor glycine site probed by site-directed chemical coupling., Foucaud B., J Biol Chem. June 27, 2003; 278 (26): 24011-7.

???pagination.result.page??? 1